Selective Depletion of a Thymocyte Subsetin Vitrowith an Immunomodulatory Photosensitizer
- 31 May 1999
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 91 (2), 178-187
- https://doi.org/10.1006/clim.1999.4695
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- Overexpression of Bcl‐XL prevents caspase‐3‐mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD‐MAFEBS Letters, 1998
- Photodynamic therapy induces caspase-3 activation in HL-60 cellsCell Death & Differentiation, 1997
- Apoptosis by Death FactorCell, 1997
- Transcutaneous Photodynamic Therapy Alters the Development of an Adoptively Transferred Form of Murine Experimental Autoimmune EncephalomyelitisPhotochemistry and Photobiology, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell DeathCell, 1996
- Rapid Initiation of Apoptosis by Photodynamic TherapyPhotochemistry and Photobiology, 1996
- The Use of Transcutaneous Photodynamic Therapy in the Prevention of Adjuvant-Enhanced Arthritis in MRL/lpr MiceClinical Immunology and Immunopathology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993